Menu
Subscribe to our Email Alerts
Home
About Us
Company Overview
Our Values
Board of Directors
Team
Scientific Advisers
Clinical Advisers
Corporate Directory
Corporate Governance
Pipeline
Pipeline
Cancer Program
Fibrosis Program
Clinical Trial
Investor Information
Welcome
Investor Fact Sheet
Investor Presentations
Media
Top 20 Shareholders
Shareholder Services
Investor FAQs
US Shareholders
Announcements and Reports
ASX Announcements
Publications
Annual Reports
Half Yearly Reports
Quarterly Reports
Research Reports
Contact Us
Contact Us
Email Alerts
Announcements and Reports
Home
>
Announcements and Reports
>
ASX Announcements
ASX Announcements
Publications
Annual Reports
Half Yearly Reports
Quarterly Reports
Research Reports
ASX Announcements
Filter by Year:
2024
2023
2022
2021
2020
2019
2018
27-Mar-2024
Update on ACCENT Trial in Pancreatic Cancer
30-Jan-2024
Quarterly Activities/Appendix 4C Cash Flow Report
18-Jan-2024
FDA Clearance Amplia's IND for Pancreatic Cancer Trial in US
https://www.youtube.com/watch?v=OZFWlTCU5ys
17-Jan-2024
Amplia Reports First Patient Dosing In Phase 2a Accent Trial
2-Jan-2024
Change of Director's Interest Notice - Dr Warwick Tong
2-Jan-2024
Change of Director's Interest Notice - Dr Chris Burns
2-Jan-2024
Change of Director's Interest Notice - Dr Robert Peach
2-Jan-2024
Change of Director's Interest Notice - Jane Bell
2-Jan-2024
Notification of cessation of securities - ATX
2-Jan-2024
Application for quotation of securities - ATX
1